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Summary Overnight oximetry is widely used for screening for the sleep apnea–
hypopnea syndrome (SAHS). The degree of desaturation at an apnea event is known
to be affected by the degree of obesity. We hypothesized that the diagnostic ability
of oximetry for SAHS is affected by the degree of obesity.
A total of 424 consecutive patients referred for possible SAHS were studied. The
subjects were classified into three groups of normal-weight, overweight and obese based
on the body mass index (BMI). The apnea–hypopnea index (X15h1) by polysomnography
was used as the diagnostic gold standard. Oximetry data were automatically analyzed to
calculate the oxygen desaturation index (ODI2/3/4:at 2%/3%/4% threshold).
The diagnostic abilities of the ODI were different in the three BMI-groups at a given
cutoff value, e.g. the sensitivity/specificity of ODI4 (cutoff¼ 15) were 54%/100%, 83%/
97%, and 98%/78% for the normal-weight, overweight and obese groups, respectively
(Po0:0001). The gender and the age had no significant effect on the ability.
We demonstrated the diagnostic sensitivity and specificity of the ODI for SAHS
depended on the BMI. Oximetry as a screening tool for SAHS may become more useful
by selection of a cutoff value appropriate for the BMI of each subject.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Oximetry is performed as a component of poly-
somnography (PSG) for the diagnosis of sleep
apnea–hypopnea syndrome (SAHS). Recently, the
usefulness of oximetry as a sole screening tool for
SAHS has become recognized in a new light because
of its economical benefit and easy applicability of
the automated analysis.1 A recent study reported
that it had 88% sensitivity and 98% specificity for
the diagnosis of SAHS.2 The degree of desaturation
at an apnea event is known to be correlated with
the degree of obesity expressed as the body mass
index (BMI).3 Therefore, we hypothesized that the
diagnostic sensitivity of oximetry for SAHS is lower
in non-obese patients than in obese patients. To
test this hypothesis, we studied the differences in
the diagnostic ability among groups of normal
weight, overweight and obese subjects.
Methods
Subjects
The records of 431 consecutive patients who were
referred for suspected SAHS and underwent diag-
nostic PSG from September 2000 to April 2003 were
ARTICLE IN PRESS
KEYWORDS
Sleep apnea;
Screening;
Oximetry;
Body mass index;
Polysomnography
*Corresponding author. Tel.: þ 81-92-565-5534; fax: þ 81-92-
566-9444.
E-mail address: nakano h@palette.plala.or.jp (H. Nakano).
0954-6111/$ - see front matter & 2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.rmed.2003.11.009
Respiratory Medicine (2004) 98, 421–427
reviewed retrospectively. Five patients with an
apparent respiratory disease (idiopathic pulmonary
fibrosis, COPD with FEV1o50% predicted), and two
patients whose PSG was technically insufficient
were excluded. In the remaining 424 patients the
PSG records were analyzed. There were no patients
with obesity-hypoventilation syndrome in the sub-
jects. The dominant type of apnea in SAHS patients
was the obstructive type in all but two patients.
According to the NIH criteria, the subjects were
classified under three groups of normal-weight
(BMIo25), overweight (BMIX25 and o30), and
obese (BMIX30). From each BMI-group we con-
structed another subjects group in which the
subjects with an apnea–hypopnea index (AHI) o5
or 425 were excluded to examine the diagnostic
ability of oximetry in relatively marginal cases.
Furthermore, to examine the effect of gender and
age on the diagnostic ability, we constructed BMI
matched male vs. female groups and BMI-matched
younger vs. older groups from all the subjects.
Polysomnography
PSG was recorded using a polygraph system
(EEG7414, Nihon Kohden, Japan). EEG (C3-A2),
bilateral EOG, and submental EMG were recorded.
The study period was usually from 9pm to 5 am.
Oronasal airflow was monitored with a thermistor.
Thoracic and abdominal respiratory movements
were monitored by respiratory inductive plethys-
mography (RIP; Respitrace, Ambulatory Monitoring
Inc., USA) which was calibrated by an isovolume
maneuver before the test. All signals were digitized
and recorded on the hard disk of a personal
computer.
Sleep stages were scored manually according to
the standard criteria.4 Apnea was defined as an
episode of an airflow cessation lasting more than
10 s, and hypopnea was defined as an episode of
reduced tidal volume estimated by RIP to less than
50% of the preceding value lasting more than
10 s.5,6 An AHI was calculated as the number of
apneasþ hypopneas per sleep hour.
Oxyhemoglobin saturation (SaO2) was monitored
using an oximeter (Pulsox3i, Minolta, Japan or OLV-
3100, Nihon Kohden, Japan) with a finger probe
simultaneously with PSG. Although the sampling
interval was different for the two oximeters (5 s;
1 s), we used only data with 5 s interval for later
analysis by adopting every fifth set of data in the
data of 1 s interval. The data were analyzed
automatically by a personal computer to detect
SaO2-dips X2%, X3% or X4% lasting for 10–120 s
with the descending portion steeper than 1%/10 s.
The oxygen desaturation index (ODI) was defined by
the number of SaO2-dips per hour of examination,
which was calculated separately at the 2%, 3% and
4% threshold (ODI2, ODI3 and ODI4). The algorithm
is compatible with the one implemented in the
commercially available software (DS-3, Minolta,
Japan) to analyze the Pulsox3i data.
Statistical analysis
The difference of subjects’ characteristics among
groups was analyzed by one-way ANOVA with
Turkey’s post hoc analysis. The w2 test or Fisher’s
exact test (if applicable) was used to compare
percentages. The agreement between the AHI and
ODI was analyzed as described by Bland and
Altman.7 The diagnostic ability of the ODI for SAHS
was evaluated in terms of sensitivity and specificity
when SAHS was defined by AHIX155,6 and the
ODI cutoff values of 5, 10 and 15 were used. To
compare the diagnostic performance of the ODI in
different BMI groups and at different desaturation
thresholds, receiver operating characteristic curves
(ROC) were constructed and the areas under the
curves (AUCs) were calculated. The comparisons
of the AUCs between for different diagnostic
variables or between in different groups were
performed by the Hanley and McNeil method.8,9 A
value of Po0:05 was considered to be statistically
significant.
Results
Subject characteristics
The subjects’ characteristics (Table 1) were differ-
ent among the BMI-groups in gender distribution
(%male: overweight 4normal-weight), age (obe-
se4normal-weight, obese4overweight), and se-
verity of sleep-disordered breathing (obese4
overweight4normal-weight).
In the subjects with an AHI of 5–25, the gender
distribution was equivalent, although the age was
still different (obese4normal-weight, obese4
overweight) among the BMI-groups (Table 2). In
these subjects, although the AHI and AI were not
different among the BMI-groups, the parameters
related to SaO2 were worse in the more obese
groups.
The BMI-matched male (N ¼ 80) vs. female
(N ¼ 80) groups had an equivalent BMI (mean 25.1
vs. 25.7), age (49.4 vs. 51.1) but a different AHI
(30.0 vs.13.8). The BMI-matched younger (X50
yeas old, N ¼ 160) vs. older (450 yeas old,
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N ¼ 166) groups had an equivalent BMI (25.1 vs.
25.1), %male (80 vs. 84) and AHI (26.7 vs. 24.4).
ROC analysis
ROC curves constructed for ODI2, ODI3 and ODI4 in
each BMI-group showed that the AUCs ranged from
0.904 to 0.990 (Table 3). The comparisons of AUCs
for ODI2, ODI3 and ODI4 in each BMI-group demon-
strated the inferiority of ODI2. The comparisons of
AUCs for each ODI among the three BMI-groups
showed the AUC was slightly lower in the normal-
weight group than in the obese group. We adopted
ODI4 as the diagnostic variable for the later
analysis. There was no statistical difference in the
AUCs between the male and female groups and
between the younger and older groups.
Sensitivity and specificity
The diagnostic sensitivity was statistically different
at each ODI4-cutoff value among the three
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Table 1 Characteristics of the subjects in the BMI-groups.
Normal-weight Overweight Obese P
Mean SD Mean SD Mean SD
N 176 172 76
Male (%) 128(73) 153(89) 63(83) 0.0005
BMI (kgm2) 22.5 2.0 26.9 1.4 34.8 4.6 o0.0001
Age (y.o.) 50.5 14.9 50.2 12.6 41.8 12.0 o0.0001
ESS 10.0 5.2 11.3 5.1 11.3 5.6 0.0504
Sleep efficiency (%) 76.3 16.6 78.5 13.7 79.1 16.3 0.1978
AI (h1) 11.8 16.9 22.1 22.7 33.0 30.2 o0.0001
AHI (h1) 18.6 19.7 31.8 24.1 44.0 30.2 o0.0001
ODI2 (h1) 17.9 15.3 34.5 19.4 54.9 25.6 o0.0001
ODI3 (h1) 12.4 14.0 27.4 19.8 46.2 27.0 o0.0001
ODI4 (h1) 9.7 12.7 23.4 19.4 41.1 27.0 o0.0001
Mean nadir SaO2 (%) 92.0 2.4 89.2 3.9 85.6 6.6 o0.0001
%Time with SaO2o90 (%) 2.2 5.0 9.4 13.7 22.3 21.7 o0.0001
BMI: body mass index; ESS: Epworth sleepiness scale; AI: apnea index; AHI: apnea–hypopnea index; ODI2/ODI3/ODI4:oxygen
desaturation index at the threshold of 2%/3%/4%.
Table 2 Characteristics of the subjects in the BMI-groups confined to an AHI of 5–25.
Normal-weight Overweight Obese P
Mean SD Mean SD Mean SD
N 82 68 20
Male (%) 63(77) 59(87) 16(80) 0.2979
BMI (kgm2) 22.7 1.8 26.7 1.3 34.5 4.3 o0.0001
Age (y.o.) 50.3 14.7 51.3 12.9 39.7 13.9 0.0041
ESS 10.0 5.5 11.1 4.9 11.7 6.1 0.2986
Sleep efficiency (%) 77.6 15.2 79.0 14.8 83.2 14.7 0.3319
AI (h1) 4.3 3.7 6.1 5.0 5.5 5.8 0.0539
AHI (h1) 12.2 5.4 13.8 5.4 14.7 6.4 0.0931
ODI2 (h1) 13.7 6.9 22.9 10.5 35.6 22.2 o0.0001
ODI3 (h1) 7.5 4.3 14.8 9.2 24.8 21.4 o0.0001
ODI4 (h1) 4.9 3.2 10.9 8.3 18.7 20.2 o0.0001
Mean nadir SaO2 (%) 92.5 1.5 90.4 2.7 89.9 2.6 o0.0001
%Time with SaO2o90 (%) 0.6 0.9 3.6 6.3 5.9 7.2 o0.0001
BMI: body mass index; ESS: Epworth sleepiness scale; AI: apnea index; AHI: apnea–hypopnea index; ODI2/ODI3/ODI4: oxygen
desaturation index at the threshold of 2%/3%/4%.
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BMI-groups, which was lower in the normal-weight
group as compared with the overweight or obese
group (Table 4). The specificity was statistically
different at each ODI4-cutoff value among the
three BMI-groups, which was lower in the obese
group than in the normal-weight group at the ODI4-
cuttoff values of 10 and 15 (Table 4).
In the subjects with an AHI of 5–25, the
diagnostic sensitivity and specificity were also
different at each ODI-cutoff value among the three
BMI-groups except for the specificity at the ODI4-
cutoff value of 5 (Table 5).
There were no statistical differences in the
sensitivity and specificity between the male and
female groups and between the younger and older
groups (sensitivity/specificity at the ODI4-cutoff of
10: male 86%/94%, female 95%/93%; younger 86%/
93%, older 86%/90%).
Bland and Altman analysis
The agreement between the ODI4 and AHI was
displayed by Bland and Altman’s method (Fig. 1).
We performed this analysis on the subjects whose
AHI value was within the range of 5–25 h1 because
these subjects were considered to have a dominant
effect on the estimates of the diagnostic ability.
The mean value7SD of the difference between the
ODI4 and AHI was 7.574.9, 2.876.4 and
0.875.9 for normal-weight, overweight and obese
subgroups, respectively. The difference in the
mean value among the three groups was statisti-
cally significant (Po0:0001).
Discussion
The main findings in this study are: (1) the overall
diagnostic ability of the ODI for SAHS evaluated by
ROC analysis was slightly lower in the normal-
weight group than in the obese group, (2) the
diagnostic sensitivity was lower and the specificity
was higher at a given ODI-cutoff value in the lower
BMI-groups, (3) the age and the gender had no
significant effect on the diagnostic ability.
It is known that the factors that exaggerate the
rate of oxygen desaturation at an apnea event
include low baseline oxygen saturation,10 low lung
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Table 3 Area under the receiver operating characteristics curve of oxygen desaturation index (ODI) for the
diagnosis of sleep apnea defined by an AHIX15/h.
ODI2# ODI3 ODI4
Normal-weight 0.904(0.02594)n 0.928(0.02267)n 0.921(0.02366)n
Overweight 0.935(0.01800) 0.953(0.01520) 0.960(0.01387)
Obese 0.979(0.01446) 0.990(0.00978) 0.985(0.01220)
Standard error in parentheses; BMI: body mass index; ODI2/ODI3/ODI4:oxygen desaturation index at the threshold of 2%/3%/4%.
nSignificantly lower than the obese group (Po0:02).
#Significantly lower than ODI3 (the normal-weight and overweight groups, Po0:05) and ODI4 (the overweight group, Po0:01).
Table 4 Diagnostic sensitivity and specificity of the oxygen desaturation index (ODI4) in three BMI-groups.
ODI4 cutoff 5 10 15
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
Normal-weight 88nn 73 70nnn 100nnn 54nnn 100
(79–94) (64–80) (58–79) (97–100) (42–65) (97–100)
Overweight 100 57 96 78 83 97
(97–100) (44–69) (90–98) (65–86) (74–88) (88–99)
Obese 100 50 100 61 98nn 78n
(95–100) (29–71) (95–100) (39–80) (91–100) (55–91)
P-value# o0.0001 0.0405 o0.0001 o0.0001 o0.0001 o0.0001
95% confidence interval in parentheses; ODI4:oxygen desaturation index at the threshold of 4%. n,nn,nnn Statistically different
(Po0:05; 0.005, 0.0001) from the overweight group by Fishers exact test.
#Difference among the three BMI-groups by w2 test.
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volume11 and high oxygen expenditure, all of which
are expected to be present in obese subjects.
Therefore, in obese subjects it seems to be possible
that even a short apnea or a slight decrease in
ventilation can cause desaturation, resulting in the
high sensitivity and low specificity of oximetry in
the diagnosis of SAHS. In normal-weight subjects
the opposite tendency is expected. The present
findings were in agreement with the expectation,
and showed that the adoption of lower cutoff value
for the ODI could preserve the diagnostic sensitivity
in lower BMI-groups, e.g. the best cutoff value of
ODI4 seemed to be 5, 10 and 15 for normal-weight,
overweight and obese subjects, respectively.
There are several limitations in the present
study. First, the study is not of prospective but
retrospective design. However, we think there is
little bias due to the retrospective design, because
we enrolled all the consecutive subjects referred to
our clinic without a screening test. Second, the
three groups classified based on the BMI were
different in the age and the gender distribution.
However, it is unlikely that these demographic
differences caused the observed differences in the
diagnostic sensitivity and specificity, because com-
parisons between BMI-matched male and female
groups and between younger and older groups
showed no significant difference in the sensitivity
and specificity. Moreover, although the gender
difference in the sensitivity (maleofemale) was
not statistically significant, it could have rather
heightened the sensitivity in the normal-weight
group which had a lower percentage of males than
the overweight group. Third, the difference of
severity of SAHS in the three groups is a very
important problem. The SAHS was more severe in
the more obese group, which could have resulted in
the higher sensitivity in that group. However, the
higher sensitivity in the more obese group can be
explained by the fact that the difference between
ODI4 and AHI was significantly higher in the more
obese groups, which was revealed by Bland and
Altman analysis in the subjects with a marginal AHI.
Furthermore, the effect of the BMI on the
diagnostic sensitivity independent of the severity
of the subjects is supported by the fact that the
subjects with a marginal AHI in which the severity
was similar in the three BMI-groups also showed a
clear tendency towards lower sensitivity in the less
obese groups. Finally, all the subjects in the
present study were Japanese, and it is possible
that the effect of the BMI on the diagnostic ability
of oximetry is different among different ethnic
groups. Therefore, further studies on other ethnic
groups are necessary to extend the present findings
to other ethnic subjects.
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Figure 1 The difference between the ODI at the
threshold of 4% (ODI4) and AHI displayed as a Bland and
Altman plot. Only the individual data in which the AHI
was within the range of 5–25 are shown and analyzed.
The mean (black line) and mean71.96SD (gray line) are
shown.
Table 5 Diagnostic sensitivity and specificity of the oxygen desaturation index (ODI4) in three BMI-groups in the
subjects with an AHI of 5–25.
ODI4 Cutoff 5 10 15
Sensitivity Specificity Sensitivity specificity sensitivity Specificity
Normal-weight 70nn 54 17nnn 100nnn 0nn 100
(49–84) (42–66) (7–37) (95–100) (0–12) (95–100)
Overweight 100 39 82 68 41 95
(90–100) (26–54) (63–92) (53–80) (25–59) (84–99)
Obese 100 33 100 50 88n 67n
(69–100) (14–61) (69–100) (25–75) (53–98) (39–86)
P-value# 0.0023 0.2042 o0.0001 o0.0001 o0.0001 o0.0001
95% confidence interval in parentheses; ODI4:oxygen desaturation index at the threshold of 4%; n,nn,nnn Statistically different
(Po0:05; 0.005, 0.0001) from the overweight group by Fishers exact test.
#Difference among the three BMI-groups by w2 test.
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There have been many studies about the diag-
nostic ability of oximetry for SAHS, but with rather
conflicting results.1 The present results showed a
relatively high diagnostic ability of oximetry. The
estimate of the diagnostic ability is considered to
be affected by many factors. Among all, the
method for signal processing to obtain the SaO2
value is very important. A longer time for a moving
average12 or a longer sampling interval13,14 can
decrease the sensitivity to detect apnea–hypopnea
events. We used a moving average time of about 5 s
and a sampling interval of 5 s, because this setting
is available in a portable oximeter for home
monitoring. We have tested the effect of the
sampling interval on the ODI.15 The result showed
the effect of sampling interval is minimal within
the range of 2–6 s. Another factor is the night-to-
night variation.16 The present study is not affected
by the variation because PSG and oximetry were
recorded simultaneously. The other factors include
the definition of hypopnea17 and the method for
SaO2-dip detection. The definition of hypopnea is
still under discussion. There has been no evidence
that a particular definition has better clinical
relevance than others.18 Many studies include
concomitant desaturation and/or arousal response
in the definition of hypopnoea. If we detected
hypopnoea events only when they were followed
by EEG arousal, we might miss some significant
events because autonomic arousal without EEG
change can cause symptoms.19 The latest definition
of hypopnea stated in American Academy of Sleep
Medicine (AASM) position paper includes concomi-
tant desaturation.20 However, the paper also stated
that the definition will not include all patients who
may benefit from treatment. The aim of this study
is evaluation of oximetry as a screening tool for
SAHS. Therefore, we adopted the definition based
on the decrease in thoracoabdominal movement
measured by RIP, which was originally proposed and
validated by Gould and coworkers.5 Finally, we
think the degree of obesity may have an important
effect on sensitivity and specificity from the
present results.
Recently, AASM has published practice-para-
meters for portable monitoring devices for the
investigation of suspected SAHS, which stated that
the routine use of type 4 monitor (oximetry alone
or with another signal) is not recommended.21 The
recommendation is considered to be based on
conflicting results in the studies on oximetry
associated with the above-mentioned causes. We
think further studies, in which an appropriate and
uniform signal processing method is used, are
necessary to establish the usefulness of oximetry
for screening SAHS.
We demonstrated the effect of the BMI on the
diagnostic ability of oximetry for SAHS. The present
study seemed to be the first one that has focused
on the effect of the degree of obesity on the
diagnostic performance of oximetry for SAHS.
However, some studies already described the fact
that false negative cases on oximetry are less
obese as compared to true positive cases.22,23 Our
finding is in agreement with these observations.
The clinical implication of this study is that the
diagnostic accuracy of oximetry is expected to
be improved by adopting a cutoff value appropriate
for the individual BMI.
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